These findings strongly suggest that GLP-1 mimetics have a positive modulatory impact on cholesterol metabolism and, in turn, dyslipidemia and atheroma plaque formation and therefore provide further protective lipid-modulating effects beyond their antidiabetic effects. This evidence concerns the gene GCG and metabolic syndrome.